Stocks in play: Abcann Global Corporation
Has completed the acquisition of Harvest Medicine Inc. pursuant to the terms of a share purchase agreement dated January 31, 2018, in consideration for, among other things, a cash payment of $1.5 million; the issuance of 1,056,338 common shares in the capital of the Company; and additional post-closing consideration if certain performance milestones, which include certain patient, revenue and profitability metrics, are achieved. ABcann Global Corporation